Loading...
  • endoscopic
  • The re-bleeding rate among patients who received adrenaline was 25% (n=12), compared with 57% (n=8) in the combination group and 31% (n=4) in those who did not receive endoscopic haemostasis. (bmj.com)
  • Patients who received combination endoscopic haemostasis had an increased incidence of active bleeding (p=0.007) and an increased transfusion requirement (p=0.002). (bmj.com)
  • Eleven of 20 patients who re-bled had repeat endoscopic haemostasis, with 45% eventually requiring surgery. (bmj.com)
  • The data reported here suggest that increased standardisation of endoscopic haemostasis is required, especially in units with provision for emergency "out-of-hours" endoscopy, performed by several individuals of different grades. (bmj.com)
  • Since the landmark study by Chung et al , 8 in which adrenaline injection of bleeding ulcers was shown to be significantly better than no treatment, multiple single centre randomised controlled trials (RCTs) have confirmed the efficacy of endoscopic haemostasis. (bmj.com)
  • 9- 20 Endoscopic haemostasis modalities that have been proved to be beneficial include either single agents (adrenaline or a sclerosant 8, 10, 12 ) or combination therapy (usually adrenaline/sclerosant plus a thermal modality such as heater probe application 11, 13- 15 ). (bmj.com)
  • 6, 7 Although trials of endoscopic haemostasis have clearly demonstrated reduced re-bleeding overall, the results have been very variable. (bmj.com)
  • 2017
  • Albany, NY -- ( SBWIRE ) -- 08/16/2017 -- Hemostasis, the body's normal physiological response to stop bleeding after a vascular injury, is a key procedure in the first line of action attempted post an injury, by the body itself or by medical respondents. (sbwire.com)
  • vascular
  • Hemostasis is defined as the maintenance of the fluidity of circulating blood while at the same time protecting the organism from life-threatening bleeding at sites of vascular injury. (springer.com)
  • tissue
  • a controller electrically coupled to the electrode carrier and configured to control the delivery of radio frequency energy to the one or more bipolar electrodes such that tissue in contact with the electrode carrier can be ablated to a desired depth of destruction to achieve substantial hemostasis. (google.co.uk)
  • a controller to control the delivery of radio frequency energy from the source of radio frequency energy to the one or more bipolar electrodes such that tissue can be ablated to a desired depth of destruction to achieve substantial hemostasis. (google.co.uk)
  • diagnostics
  • Transparency Market Research Report Added 'Hemostasis Diagnostics Market' to its database. (sbwire.com)
  • Rising global prevalence of hemophilia A and B, the most common inherited bleeding disorders, significant surge in a variety of surgeries and trauma patients, and increasing use of recombinant products are the factors likely to drive the hemostasis diagnostics market in the near future. (sbwire.com)
  • The hemostasis diagnostics market has been segmented based on product type, end-user, and region. (sbwire.com)
  • Based on product type, the hemostasis diagnostics market has been segmented into analyzers, reagents, and consumables. (sbwire.com)
  • In terms of end-user, the hemostasis diagnostics market has been segmented into hospitals, clinical testing laboratories, research & academic institutes, and others. (sbwire.com)
  • North America is likely to dominate the global hemostasis diagnostics market owing to the rising installed instrument base leading to higher sales of reagents and support services in the U.S. Beckman Coulter is the market leader in hematology analyzers in the U.S. (sbwire.com)
  • The hemostasis diagnostics market in Europe is expected to be driven by steady rise in geriatric population which would boost demand for hemostasis. (sbwire.com)
  • Disorders
  • Disorders of hemostasis cover two opposite poles, one condition is caused by undesirable clot formation, another condition is caused by the inability to produce clot and lastly a condition that involves both. (infobarrel.com)
  • The vast and continuously rising set of under-served population suffering from bleeding disorders such as hemophilia, especially across developing economies such as India, is expected to boost the adoption of hemostasis products in Asia Pacific. (sbwire.com)
  • Caldwell SH, Hoffman M, Lisman T et al (2006) Coagulation disorders and hemostasis in liver disease: pathophysiology and critical assessment of current management. (springer.com)
  • Jeanne Marie Lusher, M.D. (June 9, 1935 - September 13, 2016) was an American physician, pediatric hematologist/oncologist, and a researcher in the field of bleeding disorders of childhood, and has served as the director of Hemostasis Program at the Children's Hospital of Michigan until her retirement on June 28, 2013. (wikipedia.org)
  • device
  • A hand held applicator device for supplying hemostasis clips, on demand and in an operative condition, to properly grasp the skin of a patient thereby to perform a hemostasic operation. (google.com.au)
  • products
  • Owing to the critical nature of the procedure, the hemostasis products market has gained a prominent position in the field of medicine and health care. (sbwire.com)
  • However, saturation of the global hemostasis market and high cost structures of advanced hemostasis products are hampering the growth of the market. (sbwire.com)